Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, and HIV/AIDS Research and Interventions.
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections
Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus
The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection
Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro
Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network
Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model
Ruxolitinib and Tofacitinib Are Potent and Selective Inhibitors of HIV-1 Replication and Virus Reactivation <i>In Vitro</i>
Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv
Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages